222 related articles for article (PubMed ID: 27705895)
1. The Absorb Limits.
Gómez Menchero AE; Camacho Freire SJ; Díaz Fernández JF; Roa Garrido J; León Jiménez J; Cardenal Piris R
J Invasive Cardiol; 2016 Oct; 28(10):E122-E123. PubMed ID: 27705895
[TBL] [Abstract][Full Text] [Related]
2. Unfavorable bioresorbable vascular scaffold resorption, a cause of restenosis?
Ishida K; Giacchi G; Brugaletta S; García-Álvarez A; Sabaté M
Cardiovasc Revasc Med; 2016 Dec; 17(8):571-573. PubMed ID: 27345841
[TBL] [Abstract][Full Text] [Related]
3. Early Collapse of a Magnesium Bioresorbable Scaffold.
Cubero-Gallego H; Vandeloo B; Gomez-Lara J; Romaguera R; Roura G; Gomez-Hospital JA; Cequier A
JACC Cardiovasc Interv; 2017 Sep; 10(18):e171-e172. PubMed ID: 28935085
[No Abstract] [Full Text] [Related]
4. Treatment of coronary stent restenosis with drug-eluting bioabsorbable magnesium scaffolds.
Alfonso F; Cuesta J; García-Guimaraes M; Bastante T; Maruri R; Rivero F
Coron Artery Dis; 2017 Nov; 28(7):627-628. PubMed ID: 28644215
[No Abstract] [Full Text] [Related]
5. Treading the risky ground of coronary bifurcation lesion revascularization, the "biodegradable strategy" may represent the lifeline.
Piraino D; Buccheri D; Andolina G
Int J Cardiol; 2016 Oct; 221():577-80. PubMed ID: 27420582
[No Abstract] [Full Text] [Related]
6. Real-World Bioresorbable Vascular Scaffold Experience Compared With Second-Generation Metallic Drug-Eluting Stents in Complex Coronary Lesions.
Okamoto N; Ueda H; Yoshimura T; Chamaria S; Bhatheja S; Vengrenyuk Y; Rabiei S; Barrientos Y; Kapur V; Barman N; Sweeny J; Baber U; Mehran R; Sharma SK; Kini AS
J Invasive Cardiol; 2018 Jul; 30(7):251-255. PubMed ID: 29656280
[TBL] [Abstract][Full Text] [Related]
7. Neointimal proliferation is associated with clinical restenosis 2 years after fully bioresorbable vascular scaffold implantation.
Indolfi C; Mongiardo A; Spaccarotella C; Caiazzo G; Torella D; De Rosa S
Circ Cardiovasc Imaging; 2014 Jul; 7(4):755-7. PubMed ID: 25027457
[No Abstract] [Full Text] [Related]
8. Restenosis of Coronary Bioresorbable Vascular Scaffolds.
Alfonso F; García-Guimaraes M
Rev Esp Cardiol (Engl Ed); 2017 Jul; 70(7):527-531. PubMed ID: 28285939
[No Abstract] [Full Text] [Related]
9. First reported use of drug-coated balloon for bioresorbable in-scaffold restenosis.
Latini RA; Buccheri D; Cortese B
Catheter Cardiovasc Interv; 2017 Mar; 89(4):676-678. PubMed ID: 27649683
[TBL] [Abstract][Full Text] [Related]
10. Very late bioresorbable vascular scaffold thrombosis due to late device recoil.
Cortese B; Piraino D; Ielasi A; Steffenino G; Orrego PS
Int J Cardiol; 2015; 189():132-3. PubMed ID: 25889443
[No Abstract] [Full Text] [Related]
11. First serial assessment at 6 months and 2 years of the second generation of absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study.
Ormiston JA; Serruys PW; Onuma Y; van Geuns RJ; de Bruyne B; Dudek D; Thuesen L; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Dorange C; Veldhof S; Hebert KM; Rapoza R; Garcia-Garcia HM
Circ Cardiovasc Interv; 2012 Oct; 5(5):620-32. PubMed ID: 23048057
[TBL] [Abstract][Full Text] [Related]
12. Coronary artery perforation at the level of two-overlapping bioresorbable vascular scaffolds: The importance of vessel sizing and scaffold thickness.
Pichette M; Chevalier F; Généreux P
Catheter Cardiovasc Interv; 2015 Oct; 86(4):686-91. PubMed ID: 26122768
[TBL] [Abstract][Full Text] [Related]
13. Late-acquired scaffold malapposition and discontinuity that may be attributable to pathological coronary ectasia: Insights from optical coherence tomography.
Miyazaki T; Ruparelia N; Kawamoto H; Sato K; Latib A; Colombo A
Int J Cardiol; 2015; 186():136-8. PubMed ID: 25818756
[No Abstract] [Full Text] [Related]
14. Twenty-four months of follow-up of a "biodegradable" model for coronary artery bifurcation management. Insights from optical coherence tomography of a new interventional strategy.
Buccheri D; Cortese B
Int J Cardiol; 2016 Nov; 222():37-38. PubMed ID: 27448703
[No Abstract] [Full Text] [Related]
15. A case of subacute stent thrombosis after drug-coated balloon coronary angioplasty for in-stent restenosis under single anti-platelet therapy.
Kagawa Y; Shiode N; Kawase T; Tamekiyo H; Okimoto T; Hayashi Y
Cardiovasc Interv Ther; 2017 Apr; 32(2):170-173. PubMed ID: 26979600
[TBL] [Abstract][Full Text] [Related]
16. Drug-coated balloon for recurrent in-stent restenosis treatment: A suitable strategy.
Piraino D; Buccheri D; Cimino G; Andolina G
Int J Cardiol; 2016 Oct; 221():1084-6. PubMed ID: 27448537
[No Abstract] [Full Text] [Related]
17. Acutely malapposed bioresorbable vascular scaffold during primary angioplasty for spontaneous coronary artery dissection: Is a no-metal strategy better?
Cortese B; Buccheri D
Int J Cardiol; 2016 Dec; 224():335-336. PubMed ID: 27668707
[No Abstract] [Full Text] [Related]
18. Severe Neointimal Hyperplasia of Neoplastic Carina Following Bioresorbable Scaffold Implantation Using T-Stenting and Small Protrusion Technique: Insights From Optical Frequency Domain Imaging.
Kawamoto H; Ruparelia N; Figini F; Latib A; Colombo A
JACC Cardiovasc Interv; 2015 Nov; 8(13):e207-9. PubMed ID: 26476605
[No Abstract] [Full Text] [Related]
19. Feasibility and efficacy of bioresorbable vascular scaffolds use for the treatment of in-stent restenosis and a bifurcation lesion in a heavily calcified diffusely diseased vessel.
Naganuma T; Costopoulos C; Latib A; Sato K; Miyazaki T; Colombo A
JACC Cardiovasc Interv; 2014 May; 7(5):e45-6. PubMed ID: 24746654
[No Abstract] [Full Text] [Related]
20. Bioresorbable Scaffold Failure Due to Chronic Recoil in a Myocardial Bridge.
Giavarini A; Longo G; Chen J; Rodríguez R; Di Mario C
JACC Cardiovasc Interv; 2016 Mar; 9(6):e49-51. PubMed ID: 26803423
[No Abstract] [Full Text] [Related]
[Next] [New Search]
